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The use of boron- containing 8.mines for the amino-
alkylation of amldes has been investigated in our 
laboratories with the atm of preparing compounds which could 
be used in neutron capture therapy. The purpose of this 
procedure is to achieve selective irradiation of a neo-
plastic gro·wth by inducing radioaetivity throughout that 
tissuee Although the results obtained in destroying tumors 
have not always been encouraging, they have been such -
especially in cases not amenable to treatment by surgE~ry or 
chemotherapy - that further research is warranted .l.n order 
to develop drugH that can be used effectively in neutron 
capture therapy {Farr, Robertson & Stl.clcley, :l.95lJ.). This 
method of cancer treatment is still i.n the experimental 
stages of development, but it will, no doubt, gain the 
ac·tive interest of more clinical workers in the near future. 
It owes i.ts inception to Locher t s suggestion in 1936 
that compounds containing nuclides with a high neutron cross 
section such as boron-10 could be used·in selectively destroy-
ing or weakening cancer celis (Locher, 1936). 
The rationale for utilizing boron-10 centers about 
the ability of the non-radioactive boron-10 isotope to absorb 
neutrons. The resultant activated intermediate decays 
immediatel ·to articles. Al 
can be induced in several elements by capture of thermal 
1 
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neutrons, a suitable tal~get element is one whose. reactive 
intermediate species decays immediately with the concomitant 
emission of energetic heavy particles like alpha particle~. 
Another criterion for a satisfactory target is that it must 
have an adequately large thermal neutron capture cross 
section, which is a measure of the affinity of an i.sotope 
for the absorption of a thermal neutron. (Thls is mectsured 
in barns, where 1 barn = 1X1o- 24 cm2 ; the cross se.ctlon is 
also a function of the velocity and the energy of the neutron). 
Roron-10 in neutron capture therapy is suggested 
since its thermal neutron cross section (3850 barns) is much 
larger than that of boron-11 (0.05 barns). ~he latter f'orrns 
a "stable:u isotope when it absorbs a neutron; whereas. the 
reaction product; with boron-10 decays immediately.. Therefore, 
boronated compounds enriched with ·boron-10 are preferred. 
If' a particle haa an energy of at least 10eV 
(electron volts), it is capable of displacing orbital 
electrons thereby ionizing tissue components.. Therefore, in 
order to minimize such adverse effects, slow or thermal 
neutrons are utilized, that is, neutrons with an average 
velocity of 2200m/sec. and with _an energy of 0.02.5 ev. 
Equation 1 summarizes the events of the nuclear bqmbardment 
reaction involving boron-10. 
Eq. 1a 
The reaction-products are large by nuclear s~andards so they 
o:f _9m~..,_l5 -Jb---· __ fr_nro __ _:fhe __ site~_ofc-the--­
neutron capture reaction.· This distance is slightly greater 
than the cross section of a red blood cell; therefore, it 
3. 
follows that the lethal. radiation emitted is confined to a 
radius of approximately one or two cell diameters (Kruger,. 
194·0) ~ 
This method of attaining selective cytocidal effects 
is feasible because other e::lements such as hydrogen and 
nitrogen oceuring naturally in normal cells have low neutron 
cross sections compared to that of boron-10 (0.332, 1.88, and 
J850.barns, respectively). But since their concentration is 
much higher there would also be contributing sources of 
radiations emanating from neutron capture sites involving 
reactions with hydrogen and nitrogen. 
Eq • 2: Hl + n1 - ·~ [ H2l -~~ _· ~ H2 + y 
1 0 _1 J 1 
Eq • 3: N14 + . nl ~--> f N15J * --~ ·p + + 6014-
7 ·0 ~ 
These reactions may cause some of the undesirable tissue 
damage that has been observed in neutron capture therapy 
(Archambeau, 1970) • 
If a neutron flux of 1010 neutrons/cm2 /sec. were 
used and if the boron-10 concentration in the tumor were 
.50mg/kg. of tissue, then 86% o:f the total radiation produced 
•rin situ" would be a direct result of the boron-10 neutron 
capture reaction (Javid et al., 1952). 
However, if this type of therapy is to be practical, 
there are certain essential requirements which must be ful-
filled. 
The ~ompound shquld have high chemical and biological 
1-----------.,.t~b-i-t-i-ty along wil:n-low_t_oxicity and -nfgn--boron content. 
The boron-10 concentration should be of an adequate level 
(50 mg. B-10/kg. tissue) and the boron~to should be distributed 
equally. throughout the tissue. To accomplish this· t·he · 
compound munt be injected .int:C'avenously and not directly -into 
the suspected tumor area. This follows because the precise 
dimensions and extent of the invasive neoplastic process is 
not knmm exactly, and the .blood supply provides the only 
means of exposing all portions of the tumor to the same 
boron-10 concentration. 
The potential drugs must be highly water,.-soluble 
since they are administered to patients in rather large doses--
intravenously or intra-arterially. Ideally, they should be 
soluble at physiological J)H7 .4 to avoid toxic effects that 
might arise as a consequence of pH changes in mammalian 
systems. 
A gufficiently large differential in boron-10 concen-
tration bnbreen the neoplasm and· the adjacent normal tissue 
must exist in order to permit the coniplete eradication of. the 
turnor.without adversely affecting the tissue surrounding the 
neoplasm .. 
An adequate thermal neutron flux must be available 
:for such treatmer1t. A nuclear reactor would be able to 
supply .such demands (Soloway, 1961-J.; Parr & Konikowski, 1968). 
The.se points represent only some of the criteria for 
potential drugs tha.t are-to be utilized in neutron capture 
therapy. Perhapsnot.all of these requirements were taken 
into account by· some of the pioneer researchers like Kruger 
~--~~~~~~~~~~~~?=VT~n.~~~1~~-.~b~ut~------~------
their choice of compounds was limited to only a very few 
compounds; even 20 years ago many of the boron compounds 
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·were classified as r:;ecre·t material and were unavailable for 
pharmacological testing. 
A. wide range of compounds has been evaluated in order · 
to determine·their utility in neutron capture therapy, bu't 
few have shown any promise. Those which were used to treat 
brain tumor patien'ts failed to manifest the desired selectl'\re 
cytocidal properties. For example, p-carboxybenzencboronic 
acid and sodium decahydrodecaborate were both extremely non-
toxic, freely diffusable and low-threshold substances, and 
levels of these compounds 111: ·the tumor were higher than those 
in the normal brain tissue (Sweet, Soloway, & Wright; 1962). 
However, the boron concentration in the blood was greater 
than that in the tumor. '.rherefore, neutron irrRdiatlon of 
the tumor resulted in irreparable da.mage to the blood v-esst::Jl 
epithelium. This, in turn, caused interference with the 
normal transport from the blood to the brain of compounde 
essentlal for the normal function of the central nervous 
system (CNS). Similarly, waste products could not be 
removed efficiently by_the damaged blood vessels.· Therefore, 
cellular death resulted in part as. an indirect consequence 
of irradiation (Soloway, 1964, p.228). This emphasizes the 
need to prepare boron.:..containing compounds which would leave 
the blood to become incorporated into the tumor before 
irradiation is attempted. 
It ls conceivable, then, that the synthesis of boron-
1 ________ ·_il_1_ing antimeta*li~-~~--~~~~ p};'O~T~-~9_--b_~_a _!t'~--l;t~-----
avenue of pursuit. This approach may enable researchers to 





which could be extended to tumors other than those of the 
central nervous system, The efficacy should be increased 
.with the combination of two factors. First, inhibition of 
tumor.growth should result by virtue of the compound's being 
an antimetabolite, and second, the possible selective incor-
poration of a boron-containing anti-tumor agent into the 
proteins or nucleic acids of the neoplasm could lead to 
chromosome disruption upon neutron irradiation {Soloway, 
1959). 
Such a nuclear positioning of boron-10 atoms may 
lower the thermal neutron .flux required in order to effect 
the eradication of the tumor. In his review article, 
Soloway (1964) also mentions various types of anti-tumor 
agents which a1:-e being used. 
Present interest in our laboratories lies in the 
area of synthesis of organoboron derivatives o:r tetracyclines • 
.Antibiotics may act as inhibitors in protein synthesis. 
Actinomycin D inhibits RNA synthesis by binding to guanine 
moieties of DNA (Stocl(, 1966). The antitumor activity of 
mitomycin C appears to be associated with its ability to be 
converted to a chemically active form under physiological 
conditions. This reactive intermediate can crosslink DNA, 
much in the same :manner as alk;vlating agents do (Stock, 19661 
see also ·· Wheeler, 1962). Daunomycin (Rubidomycin) has 
cytotoxic and antimitotic activity. Di Marco (1967) suggests 
that its mode of action depends upon its corrrplexing with DNA 
1----------~~------------------ --- ----- ----c---~ ~--~-------
which . c<:tnses. conf'ormat ional perturbations at the receptor -site 
(Bell~an, 1964). ~f.lhls in turn would inhibit the abili-ty of 
7 
DNA to act as a primer in duplication reactions (DNA-
dependent, DNA-synthesis) and in transcription reactions 
(DNA-dependent, RNA synthesis). Therefore, as a consequence 
RNA and protein synthesis would be inhibited and cell 
reproduction would be arrested.· 
0 OH 
HO 
Fig. 1: XIX. Daunomycin - an anthracycJ.ine containing a. 
quinoid. aglycone chromophore, daunor11ycinone, 
in glycoslde· linkage with an amino sugar, 
daunosamine. 





tetracycline (XXc), and similarly related compounds have on. 
the biosynthesis of proteins. As a possible explanation for 
the mode of action of tetracycline, Maxwell (1967) has 
suggested that the antibiotic may compete with amino acyl 
tRNA for binding to. the recognition site of the ribosorrie-
mRNA complex. Under conditions not allowing protein synthesis, 
this competition would result in partial inhibition of amino 
acyl tRNA binding; in this case a proportion of the ribosomes 
would bind tetracycline instead of amino acyl tRNA. The 
ribosomes which had bound the latter would then incorporate 
the amino acid into the polypeptide, and their recognition,· 
sites would then again become ready to accept another amino 
acyl tRNA or a tetracycline molecule. If we assume that the 
ribosome which had bound tetracycline became inactivated, 
this would result in the inhibition of protein synthesis 
and in the removal of amino acyl tRNA from the ribosomes. 
These events appear to be consistant with the experimental 
data. 
However, more recently, experimental results indicate 
that it may be the irreversibly hound tetracycline molecules 
(in 30 S and 70 S sub units) which are responsible for the 
· anti biotic activity • Further studies on the binding of 
tritium. labelled tetr&cycline to ribosomes from various 
sources may help establish the validity of this theory 
(Maxwell, 1968). rrhe binding of tetracycline in ribosomes 
This allosteric effect may also eontribute to tetracyclines• 
inhibitory effect on protei11 E;ynthesisq 
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Although there have been numerous attempts to prepare 
useful selective cytocidal agents, most of the present 
cancer chemotherapeutic agentsate, in :fact, anti~growth 
compounds. Investigations into developing methods of pr·e-
venting tumor spread-not just tumor growth-are of extreme 
importance. Hational drug design will be possible only when 
events occuring at mol.ecular and cellular levels are better 
understood- Therefore, it is vital that studies in drug. 
metabolism and tumor biochemistry be continued. As was 
stated previously, any agent which is to be employed in 
neutron capture therapy should become incorporated into the 
tumor in order to enhance its efficacy; :Lt follows then, that 
a knowledge of both normal and tumor biochemistry will be 
invaluable. Researchers in this area have found that the 
sensitivity to drugs varies during the mitotic cycle of a 
cell. Hence, the most effective use of a drug may be 
realized when all the tumor ~ells are exposed to an adequate 
drug concentration during the sensitive stage •. This may 
also perrni t neu·tron capture· therapy to be performed with 
lower neutron fluxes. 
Since tetracyclines have·been reported to concentrate 
in certain kinds of tumors and since they inhibit protein 
synthesis, these compounds may act as useful vehicles to 
carry boron-10 to cancer cells (James, 1969). In this way 
eradication of the neoplasm may be effected by neutron 
ca ture thera • , exemplified by 
daunomycin and tetracycline, appear to have a tendency to 
inhibit p}:·o-tein synthesis, it may be profH;able to use 'these 
10 
types of compounds as vehicles for transfer:r:·ing. boron to 
tumor sites. The synthetic derivatives proposed in thl.t!. 
work are analogues of an N..;amidoalkylated pl"Oduct obtained 
under· I':1annich reaction conditions (Gottstein et al., 1959). 
Eq. /.J< 
This reaction (See Eq. 4) requires 011ly very mild conditions; 
this is prerequisite since more stringent conditions may 
lead to structural changes in the remainder of the molecule • 
. Since the hydroxy and carbonyl groups on the rings are 
believed to be important for the action of tetracycline, 
derivatives of these groups·were not considered. 
The amine compound chosen for use in this work is· 
of the diptychboroxazolidine (or 1,.3,2-oxazaborolidine) 
type; e.g. diethanolamine ester of phenyl boronic acid, 








Compared to many other boron containing compounds 
these boronates are relatively resistant to hydrolysis --
at least under ''in vitro" conditions (Weidmann & Zimmermann, 
1958; Steinberg & Hunt~r, 1960). ·This phenomemon is· 
attributed to an N --1- B transannular ini;eraction across the 
eight membered ring of the diethanclamine boronate (Brovm & 
Fletcher, 1951r Hein& Burckhardt, 1952}. 
However, because of the complexity of a product ob-
tained from a·ttempted N-amidoalkylation of tetracycline XXa 
with compound IX and formaldehyde, accompanied by the 
difficulty in intell?reting the data it was deemed advisable 
to study the Mann5.ch tYPe reactions of a model compound of 
Ring A of tetracycline - viz. 4,4-dimethyl-J-dimethylamino-













·.Data obtained from the reaction represe:nted in 
Equation 5 should facilitate- the explanation of the experi-
mental results in analogous reactions in tetracycline. 
However, various attempts to prepare Compound IV did not 
yleld the desired resul.ts. Therefore g N~amidoalkylations 
of 4,4-·dimethyl-2,6-cyclohexanedione carboxamide (X) were 
trled ·to determine if the desired N-amidoalkylated product -
could be formed under the conditions which lead to the 
formation of an organoboron complex of tetracycline. 
Therefore the pur:pose of the present studies was to 
determine if the reactions performed under Mannich condi·tions 
would be useful in preparing N-amidoalkylated, boron-c:on-
taining compounds which could be employed j,n neutron capture 
therapy .• 
~~TERIALS AND ~ffiTHODS 
All chemicals were obtained from Aldrich Chemical 
Co., Ltd. and were used without further purification. All 
melting points were. determined on a Thomas Hoover capillary 
melting point apparatus and are uncorrected. Infrared spectra 
were taken on a a Perkin-Elmer 457 grating infrared spec-
trophotometer. The maximum absorption peaks are indicated 
in cm.-1 as run in the solvent (CHct 3) or in the pellet form 
(KBr or Csi). The NMR spectra were run on a Varian A60-A 
60MHz. NMR spectrophotometer and on a Jeolco fvlH-100 100MHz. 
NMR spectrophotometer. The NMR peaks are indicated in parts 
per inlllion (8), compared to ~f:t1L'3 as the internal standard. 
Reaction products were separated by TLC using Bake:r-flex 
sili<~a gel IB-F as the adsorbent and acetone-benzene (1!1) 
or aceto:ne as the eluent. The spots on the chromatograms 
were visualized under u.v. light (both 254mp-. and 365m~.) 
and also by subsequent spraying with a 0 .J.~% solution of 
2~4-dtnitrophenylhydrazine in 2N HG1. 
13 
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Summary. of Reactions 
0 0 
/ / I '\ ~ 
· A B C H 
Ac.O'~ ·u AcO' ~ _-o 
II II IV '\. Br-
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. 1 t ·~ 
··OBr 







At gl. HOAc; B: Ac
2
0; C: IN:OHv ~r.sOH; Ds NBS, hv 
E1 PHT; F: NBS, hv G t PHT J H t PWr J I t 
t------------------·----·------ ----------·-------·--------- ·---------------- . 
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Summary of Reactions, Continued 
Nl: urea;_ Na gl. HOAc; Os EtOH, rrsOH: Pth'V,NBS; Qt PH11 ; 
R: (HCHO)x' boroxazolidine. 
1-----c--------------·---·------·--- -- -------- ------ ----- ----
EXPERIMENTAT.J It~SULTS 
A. 3-Acetoxy-_:5,5-dimethyl-2-cyclohexen-:1-one (II) 
-Method 1, according to Kiichi Arakawa (1959). A mixture of 
5 g. (0,0356 mole) of dimdeone (I) in 40 ml. glaci~l acetic 
acid was heated and stirred until dissolution was complete. 
The solution was refluxed for 10 hrs., and cooled to room 
temperature. The excess glacial acetic acid was removed on 
a rotary flash evaporator to yield 5.95 g. of a yellow oil. 
Addition of some diethyl ether yellow crystalline solid was 
filtered and washed with ether to yield 2.0 g. of a solid 
melting at 145°·-147°C. The I. R. spectrum corresponded to 
that of the starting material. The remaining oi1 product 
was distilled under vacuum. Some material sublimed at; 
approxiroately 90°-105°C (0.3 mm. Hg pressure). 'fhis was 
shown to be starting mat€rial also. (The desired product 
has a boiling point at 97°-99°C at 2,0 mm. Hg pressure.) 
'l1here was no evidence to indicate that the enol acetate of 
dimedone had been formed. 
I.R. of d.imedones ~(max,CHC1 3 ); 173L~,1705(C=O.keto 
form); 1610-1580(C=o,c~c~dimeric 
form): 
~ (max,KB~); 1630-1610(~ C=O): 
1582(\1 e>:C) J 
6orv1Hz& N.M.H.l p.p.rno(CDC1
3
) 1.06,1.10(Methyl H)J 
2.28(6-H); 2.35(4-H); 




'B.. J;.··Acetoxy;..!),5 .. •ff:lmethyl..-2.o.cyc;lohext>:n ... 1":-orie·· (11) ... Met}lc;d 2 .. 
To a. mixture: of dimeclone (I .... 1.) .. og~,O.,:t07 moles) and 
:p·vtolueneaulphonic acid monohydrat~ (20)4 goe Oq10? moles) was 
added 2?.5ml. of acetic anhy:drl<l~·· 'I'he ~rt.i.i"'.c;ed: auepensiort was 
heated to 1?.5°C over a four hour rJeriod while 150 ml. of 
distill;':lte (acoti6 acid and acetic anhydride) were collected at 
a boiling polnt of 1LW°C Q '11he reactipn :mixture was cooled to 
room temperature and. was then poured into 600 ml. of an ice ... 
·.w.··a~te-r-m-lx-tcure.-.-.. -Thec-"y·(~~H:ow-oi-l~wlrich-sl'.rpa:r.ated~was-extracted · 
wi-th .ethyl acetate ( ~.!00 ml·~ + 2 X :1..50 ml.). The. organic phase 
wa~·:then washed with cold 5% Nanco
3 
solution (6 x·;o ml.) and 
finally with ice water (6 X 50 ·mlo),. After the organic phase 
. was dried o·ver ·Mgso4 ~ the ~olven:t wa:~1 r~rnoved oh a rotary 
'i fl$?1.Sh evapo:e-atf;r:.. Several portion0 ·()f benzene were added and 
A evapora.:ted Ut!der vac.uum in order to re.mov·e thG last traces of' 
acetic anhyd.rid~.:. ·rne yield o:f crl.:vle product was 20,. og c An 
I~R. spectrum of the crude prc~duc-i; waG eo:nsisterrt with that 
expeeted of the enol acetate product. Distillation. of the 
oil ylelded 16o7 go (Oa0917 moles, 8,5.6% yield) of colorless 
liquid (b.p. 0 .. 2 82°.~86°G.,)~ 
I.R.s. 1\. (max,CHC13lo 1769(estar,C=o)r 1670( C(,, p-
unsaturated c~o) .. 
C. 3-Eth(JXY·-5v 5-dimethyl-2-·cyclohexen""l··,one (IV). 
Dimedone (I~15 g ... p 0.107 mcil€rs) and p-toluene.sulphoni.c acid 
{0.435 g.,. 0.;00191 moles) were disso1v<$.)d in a mixture of 
water formed while the reaction proceeded was collected 
in a Dean-Stark distilling trap. The benz.ene and excess 
.ethanol were removed under vacuum on a rotary evaporator 
and the resultant oil was transferred to a distillation 
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flask. The product distilled over at 88°-90°C. at 0.6 mm. 
Hg pressure. The various fractions solidified in the 
receiving flasks and yielded a total of 14.9 g. (83% yield), 
m. p • 58°- 59°C. With a rer"lux time of 6-~ hours and distillation 
at 0.13 mm. Hg pressure (ofl-bath preheated~t---o-rs-o-0c-), a 9:5%~-------
yield was obtained. 
I.R. A (max,CHC1 3) s 1642(C=O); 160J(C=C); 
100 MHz. N .M.R.J p.p.m. (DMSO-d6 ) 1.0(gem-dirnethyl-H); 
1.28(triplet-methyl-H of ether)J 
2.10(6-H); 2.27(4-H); J.92(quar-
tet~-mcthylene-H of ether); 5. 52 ( 2·-H) ~ 
D. ~·· B):'omosuQc).nimide (NBS) bromilfation of _1_:-acetoxy- .S t 
. .2-dj_Jp.ett1Y_l-2-c_yclohexen-1.-one (III). Freshly distilled enol 
acetate of dimedone (2.00 g., 10.98 mmoles) and NBS (1.953 g., 
:1.0.98 mmoles) in 3.5 ml. of cc14 were heated to reflux, and 
irradiated with u.v. light for about 15 minutes succinimide 
appeared on the liquid surface as the vlsual sign of initiation. 
Refluxing without irradiation was continued until no NBS 
remained at the bottom of the reaction flar1k. From the cold 
solution, succinimide (dry yiold 1.0 g., 92%) was filtered 
off and washed with CC1 • The CC1 .was removed on a rotary 
flash c~vaporator. After cooling., the yellow syrupy· ref) idue 
( J. 5 g.) f!olid:i.:fied. ~:·he results from t .1. c. indieatE-)d. that, 
19 
along with unreacted starting material, there was no new 
product. Attempts to crystallize the bromo.derivative from 
the reaction mixture from chloroform or ethano1 succeeded 
in the isolation of ditnedone (I .... rn.p. 148°C.) and 4-bromo-
dimedone (IV-m.p. 150°-151°c., m.m.p. with dimedone 130°C.). 
Apparently, the brominated enol acetate was too labile with 
respect to hydrolysis to permit its isolation in purified 
-~~-
&-------~:tGl"m-.~~~~~~~~~~~~~~~~----c--__:_~~~~~~~~~~~-'----~~---~ 
E. Pyrrolidinone hydrotribromide (PWI') bromiJJ§:"tion of 
3-acetoxy-5, 5-dimethyl-2-cycl_phexen-1-one (II).. A tetra-
hydrofuran (THF) s·olution of PHT (5.45 g., 10.98 mmoles in 
100 ml.) war3 added slowly to a rapidly stirred solution of 
th,e enol aceta-t0 (2.0 g.v 10~98 mmoles) in 100 ml. of THF. 
After the mixture was allowed to react for 30 minutes 9 the 
pyrrolidinone hemihydrobromide formed during the reaction 
was removed ·by filtration, and the filtered solution was 
evaporated under vacuum on the rotary evapora·tor to yield 
4.8 g. of yellow oily product. Data from t.l.c. indicated 
that one product was formed, and that all of the starting 
material had reacted. Some decomposition products of PHT 
were also present in the :r.-eaction mixture. 'rhe product was 
identical to that formed in the previous reaction. The PHT 
bromination of the enol ac~etate appears -t;o pro.ceed to 
·completion more rapidly and with fewer competing reactions 
20 
F. NBS bromination of 3-etho~:-.5~-dimethyl-2-cyclohexen-
_1-one (IV)., A 50 ml. aliquot of cc14 was add~d to a mixture 
of NBS (2.64 g-o 14.85 mmoles) and IV (2.5 g.; 14.85 mmoles). 
The reaction mixture was heated to reflux and then·irradiated 
with u.v. light for approximately 30 minutes until the 
reaction was initiated. After 40-45 minutes of· refluxing 
the reaction appeared to be completed. The succinimide 
(dry yield, 1,37 g., 93%) was removed from the cooled (25°C.) 
reaction mixture by filtration and was washed with cc14. 
The filtrate was evaporated on a rotary flash evaporator 
to yield a viscous yellow oil (3.7 g.). Since the desired 
product could not be crystallized, a distillation was under-
taken. The product boiled at 84·0 -85°C. at 0.12 mm. Hg 
( 0 0 . 4 ) pressure or at 127 -1.31 c. at 1. rnm. Hg pressure ,. However, 
when. the heating bath temperature reached 160°-165°C .. 
decomposition occurred, accompanied by the evolution of white 
fumes and a rapid decrease in pressure. ~:he results from 
I.R. spectra and from t.l.c .. indicate that all the .fractions, 
although colorless, were mixtures containing·varying amounts 
of starting materiai, 2- and 4-- bromo substituted enol e·ther, 
and 2- and 4-bromodirnedone. 
I .R. of 2·· bromodimedone s 1\ (max,CHC:t 3)' 1710 ( \.] C=O, 
diketone}; 1668 ( '"? C=O, 
dime ric enol); 1609( \lC=O, 
dhneric enol) 
,A ~ ,KBr)! 1580-1570(\JC=O, 
t-------------c-------------- ----------- ----- -- ----------------------------------------------·. 
~C=C, dimeric enol) 
I~ R. of lJ.- br.omodi.rnodo:ne t See part H of Experimenta~ 
Results. 
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G. PHT · bromination of .J.-et.hQ.~:Y::.i12::-dJmethyl-2-cyq_l<;>hexen-
1-one (IV}. Pyrrolidinone hydrotribromide (5.9 g., 11.9 
mmoles) in 100 ml. of 'l'HF was added slowly to rapidly stirred 
solution of the enol ether of dimedone (2 g., 1:ti.. 9 mmoles) 
·in THF (200 ml.). After five minutes the solution became 
somewhat cloudy. The turbidity of the solution was caused 
by the formation of the THF insoluble pyrrolidinone 
hemihydrobromide. After 30 minutes the reaction mixture was 
filtered in ord~o reme>ve t:ne--(:pyrrori-a-tn-arre-)zH-Br-(-,)-.6-g.---). 
Subsequently, the solvent was removed under vacuum on a rotary 
evaporator to yield 4.6 g. of yellow syrupy oil. The results 
of t.l.c. indicated that some unreacted starting material 
remained, and·that there were two different brorninated 
derivatives of the enol ether as well as some 2- bromo-· and 
lt-- brcmodimedone in the reaction mixture. 
H. PHT brom:i.nation of_5...t..5:dim~th.Yl-1, 3-cyclohexan~.Q.iorw 
ll_L._ c·ompound I ( 500 mg. , 3. 56 mmol.es) and pyrrolidinone 
(312 mg., 3.67 mmoles), dissolved in 80 ml. of IJ.'HF, were 
stirred vigorously. A solution of PH'r (1.77 g., 3.56 mmoles 
in 70 ml. of 'l'HF) was added slowly. The reaction began after 
a few minutes as evidenced by the formation of a precipitate, 
pyrrolidinone hemihydrobromide. The total addition time 
was 60 minutes, and the reaction mixture was allowed to stir 
at room temperature for an additional two hours f The pre·w 
ci itate was removed by filtra·tion and was washed with THF 
::.md Et2o. As the solvent was be:i.ng removed under vacuum on 
the rotary evaporator, addit:to:n.alpyr:colidinone hernihydrobrornide 
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precipitated. This was also removed by filtration. 
Evaporation of the solvent under vacuum was continued. The 
residual yellow liquid was dissolved in ether and was washed 
with 0.1N HC1 to remove the 2-pyrrolidinone and any of its 
. hemihydrobromide. Results of ·t.l.c. run on a sample of the 
dried ether solution indicated that there were at least five 
components in the reaction mixture. There was some 4-bromo-
dimedone and unreacted dimedone, but the principal product 
was 2- bromodimedone. There· were two other unidentified 
products, wnich may be 2,4-dibroroodimedone and 2,2-dibro-
modimedone. (The latter converts to the former dibromo 
derivative upon standing. Blout et al1 _1946). No attempt 
was made to isolate and characterize these products. 
I. ~+..:-Bt:QitLG:..it-5_·-dime"l!]}yl::l_,J--c:~:.PlohexanediolliLl'Lll..t 
~1ethod L__..,__]jyg_roly:sis qf_lii. A freshly prepared portion 
of III (2 g., 7.7 mmoles) in 15 ml. of 50% H2so4 was heated 
on a steam bath for 15 minutes. The reaction mixture was 
poured into 25 ml. of ice-water, and the resultant solution 
was extracted with Kt2o ( 3 X l.J.O ml.). The organic layer was 
subsequently washed with 5% Na2co3 solution (3 X 40 ml.). . ,, ......... .,.._ .... ,_ . 
rrhe. aqueous layer was acidified with HCl, and the separa:ted 
produc-t was extracted with CHC1; (3 X 25 ml.). After the 
solution was dried over Na2soL~, the solvent was evaporated, 
to yield 1.6 g. of a yellow-brown oil. Crystallizatlon was 
roduct has a ~reat tendenc 
to oil. The rep()rted crystallizing solvent ·e·thanol diluted 
with water, was not as effective as chloroform or carbon'' 
----
tetrachloride. The required product, VI, was obtained in 
53% yield (0.9 g., 4.1 mmoles), (m.p. 150°-151°0.), 
I. R.: · i1 (max, CHC1 3) 1720-1710 ( 1, .3-dil'.:etone); 
166.3(\"7 C=O of dimer); 1605(v c::c of dimer); 
1\(max.Csi) 1640-162.)('1 C=O); 1595('V C=C). 
I 
2) 
60 MHz.N.M.R.: p.p.m.(CDC1J + some DMSO-d6 ) 
1.2.3(Methyi-H); 2.24(4-H; keto formh 
2.48(4-H; enol form); 4.17(6-H; 
same carbon as Br); 5.!J:9(2-H). 
100 MHz.N.l'll.Rd p.p.m. (O:MSO-d6 ) 1.12(Methyl-H)J 
1.52(multiplet;4-H); 2.02; 2.44(2-H); 
4.2(6-H; on same carbon as Br); 
lO.O(enolic H). 
J ~ !.!'·~Bror£2.::iL5-dimethy:J;-~y_clohexane<!1..9J:li9 {V:Il: 
~·1etl]_Q..<i . .?.-H:td:t:.91~L@..:.i.S .Qj' V. The n1ethod was the same as that 
used for the hydrolysis o:f the corresponding brominated enol 
acetate. From freshly prepared V (2 g.-, 8.1 mmoles) only 
0.18 g. of the required 4-bromodimedone could be isolated in 
purified form. The low 10~ yield resulted because there 
was difficulty in separating it from 2-bromodimedone. 
K. At~emEted_synthes:i.:_s of 5,5-dimethyl-L~-dimeth¥lamino-1, 
. 3-~9_i[Clohexanedione (VIIl 
A portion of 4-bromodimedone (169 mg .. , 0.77 mmoles) was 
dissol 'red in 60 ml. of Et2o. Dimethylamine gas was bubbled 
throu.h the solution until a:> roximately 500 mg. (11 mmoles) 
had dissolved. Almost as soon as the addition of ditnethy;;.. 
lam:lne. had begun~ an oil began ·to separate :from the s·olution. 
'fhe reaction flask was f'i tted with a condenser through which 
water at 0°C. circulated, and the reaction mixture was 
stirred at room temperatui"e for 24 hours, The excess 
dimethylamine and solvent were removed under vacuum on a 
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rotary evaporator to yield 210 mg. of brown oil. The product 
was dissolved in a small amount of water, and the solution 
was stirred vigorously in a flask containing Et2o to which 0.1 
N HC1 was added dropwise. At a pH value o:r 8, the two phases 
were poured into a separatory funnel and the ether layer 
was separated. The aqueous layer was added to another portion 
of ether, and more HC1 was added. The ether solution was 
dried with Na2so4 , and the solvent was evaporated. The I.H. 
spectrum of the product was the same as that of' the starting 
material, 4-bromodimedone. There was no evidence indicating 
that 4-dimothylaminodimedone had been formed; its presence 
in any of the subsequent ether extracts or in the aqueous 
layer could not be confirmed. 
The reaction was also performed in benzene and ethanol. 
No 4-dimethylaminodimedone could be detected in either re-
action, but in the case of the reaction run in ethanol 
. 0 
approximately 2mg. of dimethylammonium bromide {m.p. 13L1- ·-
:l350C.) was isolated. (This represented about a 1% yield of 
the theoretical amount.) 
The reaction was also performed in liquid dimethylamine. 
A portion of 4-bromodimedone (0.982 g., 4.25 nm1oles) was put 
i~l a 25 ml. flask, which was flushed with HNii[e 2 before the 
flask was cooled in li uid nitrogen. Ap roximately 15 ml. of 
liquid HNMe 2 was collected in 'the cooled f1as1c. The flaslc , 
·was fitted with a stopper in which there was a fine capillary 
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tube, The reaction flask was then placed in a 2 1. Parr 
autoclave (or bomb) which contained some liquid N2• The top 
of the bomb was bolted down securely, and the gas outlet 
valve was closed. After the bOinb had warmed up to ro.om 
temperature the pressure inside the bomb was 500 psi. The 
reaction mixture was maintained inside the bomb for 21-t hours. 
The gas outlet valve was opened slightly to allow the gas to 
escape slowly. When the pressure inside the bomb had reached 
atmospheric pressure, the bomb was opened and the reaction 
flask was removed. Most of the liquid HNMe 2 still remaizied 
in the flask. The solution had a faint yellow color ·- almost 
colorless, but uponexposure to. the air the color gradually 
became brownish. · 
Most o:f the HNMe 2 was allowed to evaporate at atmos-
pllerlc pressure and room temperature, and the residual amount 
was removed under vacuum on a rotary evaporator (20 mm. Hg; 
)0°C.). Data from t.l.c. indicated that the product was a 
mixture. I.R. spectra of the crude product showed that the 
product is probably a salt of a secondary amine ( vrNH2,2760 
and 24 30 cm··l • ) • i.e • the d imethyla.mmoni urn salt of 4-bromo-
dimedone, Standard column chromatography on alumina, dry 
column chromatography on silica gel, and ion exchange chroma-
tography methods all accomplished separation of various 
reaction products, but none of tJ1ese products could be shown 
to be the desired aminated product. 
L •. 
.9'...9~~x-~~<2!!~. (VII) •· The sa:me procedure outlined in part 
c. of the· above was used with the exception that liquid 
ammonia was the solvent. 'rhe wo:ek-up of the reaction mixture 
afforded 4-bromodimedone, the starting material. Other 
uncharacterized products were present, but there was no_ 
evidence that the desired prC?duct (VII) had been formed. 
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M. 4J4-dimethyl-.2, 6-cxclohexanedione carboxamide (X) 
(procedure of Scarborough, 1961). Dimedone (20 g., 0.15 moles) 
and urea (18 g., 0 .30 moles) were ground together with a 
mortar and pestle and .the powdered mixture was transferred to 
a 250 ml. round bottom flask. The f1ask was then immersed 
in an oil bath at 137°0. ~f.lhe temperature of the bath dropped 
5°C., but the temperature of the oil bath was maintained 
between 132° -138°C •. for 20 minutes. The mixture whieh mel ted 
at 132°C. became red in color. The cooled reaction mixture 
was dissolved ln 150 ml. of hot MeOH, heated with Norit A 
and filtered. The resultant yellow solution was mixed with 
250 ml. of O.l N HC1. 'The solution -v1as cooled to 4°C. for 
two hours. The crystals which formed were removed by vacuum 
filtration and washed with·a cold methanol-water mixture. 
~rhe dried crystals weighed 3.7 g. (m.p. 147°-·148°C.; mixed 
m.p. with starting material-·approx. 130°C .. ). Concentration 
of the solution yielded an addi tiona]. 3. 2 g, 
I.R.:. \ (max,C!1C1J): 16LW-·1625(C=---C-C!!:O); 1580(amide 
I & II). 
60 M'Hz. N.M.R.t p.p.m. {CDC1
3
): 1.1(methyl-H); 2.38,2.51 
(protons in 3- and 5-posi·tions); 6(broad; 
1-H • 
100 f·;ffiz. N.M.R.r p.p~m. (Dr:ISO-d6)~ 1aJ~1.4(mult:iplet)~methyl­
H; 2.24, · 2.65(proton in 3·- and 5-positions) t 
7 • 2 7 and 8 • 4o ( 1-H ) • 
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N. Attempted O-a6etylation of 4,4-dimethyl-2,6 cyclo-
hexanedione carboxamide (X). To a 5 ml. pear-shaped flask 
containing 0 .18 g. of X ( 1 mmole) and 0 .19 g. of' p-t oluene-
sulphonic acid monohydrate ( 1 mmole) were added 3 ml. of 
acetic anhydride.. 'rhe reaction mixture, which became black 
almost immediately, was refluxed for two hours. Subsequently, 
about 1 ml. of solvent was.distilled in order to remove any 
acetic acid that may have been formed.· The remainder of the 
solvent was removed under vacuum on the rotary evaporator. 
Several portions of benzene were added and likewise removed 
under vacuum. However, acetic anhydride was still present, 
as evidenced by its acrid odor. 'l'he reaction product was 
then distilled under vacuum using a "short path,. distillation 
head. 'l'he flask was heated in a hot air chamber up to 270°C. 
(pressure 0.1 mm. Hg). The dis·tillate (0.247 g.- yellow 
liquid) was placed in a Jmm X 75 ml. column containing 
neutral alumina and was eluted with petroleum ether and with 
benz'ene. Approximately 80% of the reaction mixture was 
recovered. 'l1he I. R. of the fractions obtained indicated 
that starting material wa~ recovered. There was no evidence 
indicating the formation of the required enol acetate. 
o. At:temn_te<:LQ::-~1.11S:Y.lat_1on_ o·f 4 2 4--d~methyl--2,6-.c;yclo­
hexan~d.i ory_~- carboxami_QE__(!h A mixture of 1. 065 g. ( 5. 81 
mmoles) o:f compound X and 0. 03 g. of p--toluenesulphonic acid 
m~nohydrate in a mixture of 1.35 ml. (19.6 mmoles) absolute 
ethanol and 1 ml. benzene was refluxed for twelv 
an apparatus fitted with a Dean~-stark distillation trap. 
After the r<1action mixture had cooled to room temperature, 
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the mixture was filtered and the solvent was removed on a 
rotary flash evaporator yielding 1.06 g. of product. I.R. 
spectral data and t.l.c. showed that the product was starting 
material. 
P. NBS bromination of 4,4-dimeth~2,6-dioxocyc!ohex~ne 
£N~oxamide (::U. A mixt.ure of X (1.415 g., 7.73 mmoles) and 
NBS (1.372 g., 7.73 mmoles) was added to 20 ml. of cc14 • The 
react~ on mixture was brought to reflux, after wn1cnrt was 
irradiated with u.v. light until succinimide appeared floating 
on the cc14 • After refluxing for an additional.hour all of 
the NBS seemed to have reacted. During this t.ime red fumes 
Wf~re observed; this suggested that bromine was being produced 
at a rate higher than usual. ~t'he succinimide ·was removed by 
filtration of the hot solution and it was washed with 
additional portions of CC1L~· .After drying, the succinimide 
weighed 0 o 84 g. ( 95% recovery). A yellow-brown oil ( 1.4 g.) 
was obtained when the solvent was removed under vacuum. 
Crystallization from CHC1
3 
afforded 0.24 g. of. 2-·bromodimedone. 
and unreacted starting material (X) was recovered :in a yield 
of 0.98 g. Non~ of the desire~d 3-bromo-4,4-~-dimethyl-2,6-
cyclohexanedtone carboxamide was isolated nor could its 
presence be detected, 
Q. PHT_~gmil.:!fttio_D. of __ .!L_!±-di~~_ihyl-2 J)-c;t9l.Qttexanedion~ 
_2,?-rbq_~~·gni_de DD_. A solution of PHT (1.35.3 g., 73 mmoles in 
--~---- ··-··--·-·--··--·--- ----·--···--·- -·- ---···- ---····- --··---·--·------·-·--·-·-
60 ml. ·of THF) was added slowly to a r?.q)idly stirred solution 
of X. (500 mg., 2. 73 mmoles in 60 ml. o.f THF). The addi-ticm 
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was complete after 45 minutes, but the reaction had not been 
initiated; i.e. no pyrrolidi:none hemihydrobromide had formed. 
The reaction mixture was maintained at toom temperature while 
it was irradiated with u.v. light for a period of 15 minutes 
After this time there was no visible change in the reaction . 
mixture. Irradiation was discontinued, a:nd the reaction mix-
ture was heated to reflux. During this time, the color of the 
solution changed from yellow-orange to almost colorless. 
N-e-e-d-l:e-riRe crystals formea-in the cooled .reaction mixture. 
Results of t.l.c. and m.p. determinations showed that the 
crystals were the same as those obtained in other PHT bromi-. 
nations (m.p; 131+0 -136°C.). The compound was pyrrolidinone 
hemihydrobromide. However, t.l~c. analysis of the filtered 
solution from the reaction mixture indicated that only the 
starting amide was present; no other compounds could be 
detected. 
R. A ttem:gted_~'iYDthesis of_ 6- { 2 1 2...:9.1.!f1eth:tl.:J.Ll:-dio~ocyf:lQ::: 
h~xylc~boDX1a~nomethxll-2-nh~~~!t3,6~~di~~~zabor~ 
l:h.l.60Loc·~ane-l:· XIYl. A mixture of 4t4-dimethyl·-2,6-cyclo-
hexanedione carboxamide (X-900 mg., 4. 91 m.moles), paraformal--
dehyde (180 mg., 5.4 mmoles), and .B-·phenyl. diptych boroxazolidine 
(IX-939 mg., 4.91 mmoles) was added -to 60 ml. of' abs~lute 
ethanol. The reaction mixture was heated slowly to reflux 
while being stirred constantly. During t.he 30 minute reflux 
pariod, the color of the reaction mixture became orange and 
· awed: -N·- ( 2-phenyl-1, 3, 6, 2 dio:xaza · 
----- ---------·-
1~--------'-----------'--------·-·-'------·- . 
borabicyclo [3. 3. 0] oetylmethyl) ·- 5" 5-·dimethyl-1, J~·cyclohexanedione-
2-carboxamide, 
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changed· to yellow,· After the reaction mixture had cooled, 
the solve1rt was removed on a rotary evaporator. Crystalliza-
tion of the product was attempted from a diethyl ether-
petroleum ether mixture. Some white solid material was ob-
tained. The I.R, spectrum of the material was identical tQ 
that of the starting boroxazolidine (IX.). The compound did 
not melt at temperatures up to 320°C. The results of t.l.c. 
showed that some of the boroxazolidine remained in the reaction 
mixture along with some of the starting amide and one unidenti-
fied product •. From the thin layer chromatogram, it is 
qualitatively determined that the amount of starting amide 
had decreased and that an appreciable amount of the unidenti-
fied product had formed. Since 87% of the boroxazolidine 
was recovered and some was still in the reaction mixture, the 
amount unidentified product can not be accounted for if it is 
a.8smned that it is the Mannich base; too much boroxazolidine 
would have been required. The reaction was repeated under 
the same oondi tions with the excep·~ion that an equimolar 
amount of triethylamine was added, The findings were 
essentially those found in the above. None of the required 




As a precursor for preparing the title compound, 
4-bromo-5, 5-dimethyl-1, 3-cyclohexanedione (or l-1-- bromo-
dimedone, VI) was required. Direct bromination with Br2 in 
acetic acid, N-bromosuccinimide (NBS), or pyrrolidinone 
hydrotribromide (PHT) resulted in the formation of 2-bromo-
dimedone. Arakawa (1957b) reported that ll--bromodimedone VI 
could be synthesized by hydrolysing the bromination product 
of the monoenol ether (or acetate) of dimedone. Several 
attempts to repeat Arakawa •-s method of preparing the 3-acetoxy-
5,5-dimethyl-cyclohexa.none (II) by refluxing dimedone in 
glacial acetic acid failed. A standard method for preparing 
enol acetates by reflmcing the enolizable carbonyl compound 
(e.g. dimedone) in acetic anhydride containing p-toluenesul-
phonic acid resulted in an 80%~yield of the desired product 
(Frank & Hall, 1950). Whereas Arakawa obtai~ed an 80~ yield 
of the methyl enol ether by refluxing dimedone in anhydrous 
methanol containing some concentrated H2so4• up to 95'~ yields 
of the corresponding ethyl enol ether were realized when the 
reaction was performed in refluxing benzene which contained 
absolute ethanol and p-toluenesulphonic acid. '1.1he water 
formed during the reaction was removed by azeotropic distil-
lation and was collected in a Dean-Stark trap. 
of the two roducts (i.e. the enol 
acetate and the enol ether).by T.L.C. methods indicates that 




higher yields as compared to the enol acetate. 
The conditions under which the NBS brominations 
(or Wohl-Ziegler brominations) were performed favor free 
radical substitution in which a hydrogen atom acts as the 
leaving group. The initiation step of the reaction requires 
that NBS be irradiated with u.v. light to effect the homo-
lytic cleavage of N-bromosuccinimide into a bromine atom and 
the succinimidyl radical (See Horner & Winkelmann, 1964, 
House, 1964a; Djerassi; 1948). 
0 0 
0 Br ~ C} + Br· 
0 0 
Originally it was believed that.the succinimidyl radical was 
responsible for propagating the reaction. However~ more 
recent evidence suggests that it is actually the bromine 
atom that is the chain carrier. This view first suggested 
by Goldfinger (1953;1956) is substantiated in part by 
studies on the competitive brom:i.nation of substituted toluenes 
which showed that molecular bromine, NBS, N-- bromotetra-
fluorosuccinimide and N-· bromotetramethylsuccinimide have 
identical reactivities and that N-bromoacetamide and various 
N":"bromohydantoins have very similar reactivities (Walling, 
Rieger, & 'fanner. 1963; Walling & Hieger, 196.3; Russell & 
Desmond, 1963; Russell, DeBoer, & Desmond, 1963; Pearson & 
Tuleen & Readio, 1963) • 
.After the formation of thE~ bromine atoms during~ the 
:1:niti.at:ton of" the reaction the main propagating reactions 
which occur are represented by the following equations& 
--~-~-~--~ ~------~ 
Br• + RH ~ 
0 
'\ 
Q-Br + HBr 
.0 




--~> RBr + Br• 
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The HBr formed during the course of the bromination 
combines with NBS in a fast ionic reaction to liberate Br2 • 
Therefore, the function of NBS is to provide a low, steady 
state concentration of Br2 while at the same time maintaining 
a low concentration of HBr, thereby preventing or minimizing 
the occurence of undesirable side reactions, such as hydrolysis 
of the enol acetate or enol ether. 
If the compound to be brominated contains an alkenyl 
double bond, it is the allylic hydrogens - not the vinylic 
hydrogens - whieh are abstracted ·by the "electrophilic" 
bromine radical. 1.l:his occurs becam:Je the resultant allylic 
radical is stabilized by resonance. 
No such stabilizing eff"ects are realized by the l"adical formed 
by vinylic hydrogen abstraction. 
When the alJ.ylic radical is unsymmetrical, a mixture 
of the two possible products is obtained. However, the 
presence of functional groups may affect the position of 
substitution. Electron withdrawing groups like -COOH, -COC1, 
----
_· --crr;-so2cr,-Ertc-;-deaat-tva:tB--cc.-carbons-with-respect-to--free-----~-~~-~ -~­
radical attack. The methyl groups of some compounds like 
acetic acid and acetyl chloride donot.react at all by free 
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radicals. This is contrary to that experienced in the, 
electrophilic halogenation of compounds containing a carbonyl 
group in which only the ~·position is substituted. For 
example, aldehydes and ketones may be halogenated in the 
<X -position with bromine, chlorine, or iodine, and the 
OC hydrogens of carboxylic acids may be replaced by bromine 
or chlorine in the Hell-Volhard-Zelinski reaction (March, 
~968). Instead of using Br2 for halogenating ketones, NBS 
may be utilized in brominating a pos~~i~c~-to~a~caroonyi~--------~ ------
group. Although bromination of ketones by NBS is often 
initiated by light or peroxides,.the reaction itself does 
not appear to proceed by a free radical mechanism. Ketones· 
have been brominated by NBS in the absence of both light and 
peroxides ( Schmid & Karrer~ 1946). House (1965b) 
suggests that the bromination occurs only after a sufficien·t 
HBr coneen~cration is built up in the reaction mixture, and 
thereafter, the reaction commences with electrophilic attack 
on the enol and proceeds by an ionic mechanism. This would 
result in the formation of 2:...bromodimedone (XVIII), the 
produc·t that was actually isolated under the reaction con-
ditions used. A free radical mechanism would have favored 
4-bromodimedone (VI) as the major product. There was no 
evidence suggesting that any appreciable a.m0'\,1nt of LJ •. _ bromo--
dimedone was formed. 
From the NMR spectrum of dimedone in CDct 3 at room 
tem erature it was calculated that 25% of the dirnedone existed 
-- ------ -- - ---"--
in the enolic form and 75~{ ln the keto form. The concentration 
of dimedone in CDC:l. 3 was approximately equal to tha:t in CC11." 
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during the NBS bromination.reaction. Since chloroform is 
more polar than carbon tetrachloride, the degree of enoliza-
tion of dimedone will be greater in chloroform. At higher 
temperatures the keto form is favored (Yogev & Mazur, 1967). 
Therefore, under the reaction conditons the keto form will 
predominate in refluxing cc14 . But since it undergoes facile 
enolization, the electrophilic bromination occurs without 
difficulty to yield 2-bromodimedone (XVIII). 
J)o 0 B~, -'-o' o:--~ 0 OH 
Bt 
Io.- Ib XVIII 
Hmvever, predicting the position of substitution in 
the enol acetate or the enol ether of dimedone proves to be 
more difficult. 'rhe hydrolysed bromination product yields 
J~·- bromodlmedone, bu:t this fact does not give any indication 
ii' substitution occurred between the carbonyl and the gem-
dimethyl substituent or in the allylic posi·tion. In the case 
of the enol ether some 2-br.omodimedone along with the major 
product, h-bromoc..limedc:me~ was isolated. Arakawa (1.957a) 
also t'(~portf~d that NBS bromination of 5-methyl-19 3~-cyclo­
hexanedione yielded the 2~- bromo l)roduct only. Therefore, it 
appears_"Gha"C presence of one or two electron donating groups 
in the 5-posi ti.on determines if bromination occurs predomi-
1--------'n-a-t-e-l-y-in-the-2---pGS-i-t~i-on-or--~n 
r(:;sp<?!cti vely. 
As sugger=:~ted earlier, resonance stabilization of 
----
-------·-
reaction intermediates may not be the factor deciding the 
position of bromination; the direction of bromination may be 
determined more by the subtle changes in the electron densities 
and in the strength of the C-H bond at the 2-, 4-, and 6-
positions which result from the presence of various electron 
withdrawing or donating groups in the molecule. 
· It has been reported that a bromine substituent a:. to 
a phenylhydrazone group can react with Brady's reagent (2,4-
dinitrophenylhydrazine in aqueous methanol containing H2so4) 
to yield the corresponding osazone (Ramirez & Kirby; 1952, 
1953). Therefore, Arakawa boiled the 2,4-dinitrophenyl-
hydrazine derivative of monobrominated 5,5-dimethyl-3-methoxy-
1-cyclohexanone in Brady's reagent and from the reaction 
mixture he obtaint~d a product wh.ose elementaf analysis agreed 
with that of the osazone .of the demethylated starting material. · 
Arakawa conc1ucled, therefore, that th.e bromine was <X. to the · 
carbonyl group. Demethylation was probably preceeded by 
osazone formation; otherwise some of the tris- (2 ,1}-dini-
trophenylhydrazone) would have been rormed, 
Osazone formation may have proceeded via the following 
scheme. Since the kinetic studies of' this reaction are not 
available, this proposed scheme does not imply that this 
reaction has been classified into a f'ixed mechanistic category 







_, _ _ 
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~~------------------.-H~/N-:No,. _O_M_e_. --------
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This type of mechanism would tend to substantiate 
the view that bromination did occur in a position to the 
carbonyl. However, this does not preclude the possibility 
that bromination did occur in the allylic position. It has 
not been reported in the literature, but upon inspection of 
Courtauld models, it' would appear that substitution of 2,4-
dinitrophenylhydrazine would be sterically favorable in 
either the 4- or 6- position. If bromination had occured in 
would be stabilized by resonance as in the former case. 
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In the absense of any data other than an elemental 
analysis the evidence does not appear conclus.ive enough to 
permit the unequivocal assignment of bromination in a 
position adjacent to the carbonyl group. 
Pyrrolid.inone hydrotribromide (PHT) has been shown 
to be a very selective brominating agent for the preparation 
of c::::£. -haloketones. rrhe relative activities of a ketone, 
an alkene, and an enol acetate towards bromination in tetra-
hydrofuran at room temperature by PHT are ketone ) ) alkene)) 
~ e, l 969). Although both NBS and 
PHT can be utilized for bromlnating a ketone in the o:. -position, 
PHT differs from NBS ln the brominat:Lon of a double bo~nd for 
it results in the formation of a trans-dibromo addition 
product rather than a bromoallylic product. During the . 





~ E-r2+ (pyrrolidinone) 2 •HBr 
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+pyrrolidinone. 
(Pyrrolidinone) 2 •HBr is insolub1e in THF so that its presence 
gives a visible indication that the reaction has begun; its 
insolubility also facilitates the isolation of the.product. 
When a ketone is brominatedwith PHT, HBr will be formed. If 
it is necessary or desirable to remove it from the reaction 
mixture, this may be done effectively by adding an equimolar 
amount of pyrrolidinone to the reaction mixture before 
commencing the reaction. Although this may result in a 
dimunition of the selectivity o:f PHT, dilution with THF will 
restore the reagent's selectivity. 
As expected, bromination. of dimedone by PWl1 afforded 
2- bromodimedone (XVIII) predominately; whereas, 2--carba-
moyldimedone (X) was not bromina:.ted at all, even after irradi-· 
ation with U.V. or after refluxing. Only the startlng material 
was recovered. 
NBS bromination of.the enol acetate of dimedone (II) 
yielded one product. When this enol acetate was brominated 
with PHT, the product obtained had an Rf value identical to 
that obtained for the NBS bromination product. The PH11 
brominatlon began as soon as the PHT was added to the enol 
letion h1 about 15 minutes. Some of 
the starting material· in the NBS bromination had not _reacted 
after 45 minutes, 
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The brominations of the enol ether were not as rapid 
nor as clean. Both the PHT and NBS brominations yielded 
products which, when hydrolysed,lead to the isolation of 2-bromo-
and 4-bromodimedone. A small amount of 2-bromodimedone in the 
unhydrolysed NBS reaction mixture was detected by t.l.c., 
whereas 2-bromodimedone as well as some 4-bromodimedone were 
found in the PHT reaction mixture. These products were no 
doubt formed by the action of the HBr which was formed during 
the course of the PHT bromination. This hydrolysis could 
have been prevented at the expense of loss in selectivity by 
adding some pyrrolidinone to the substrate beforre addition 
of' the PHT. The selectivity could have been regained by 
diluting the reactants with more tetrahydrofuran. This was 
not deemed necessary since it was the hydrolysed product 
which was required, 
The results of t.l.c. indicated that tho major pro-
ducts of the NBS and the PHT brominations were the same • 
. Therefore,. it would appear that the NBS bromination may have 
proceeded by an ionic mechanism rather than a free radical 
mechanism. 1J.lhe bromination products resulting from the use 
of commercially available NBS were identical to those .obtained 
by using NBS which had been freshly recrystallized to remove 
any molecular bromin~. Although the usual free radical con-· 
ditions were utilized in all the NBS brominationsi no attempts 
were made to exclude oxygen from the reaction system. Oxygen, 
have been -oresent in a sufficient-
ly high eoncentration to preclude a free radical bromination. 
It appears that the reaction conditions favored an . 
----
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electrophilic substitution occurring by an ionic mechanism. 
Since the products obtained by NBS and PHT brominations are 
the same for the enol acetate and for the enol ether, both 
reagents seem to demonstrate similar selectivity for bromi;.;. 
nating in a position CG to a carbonyl group. As stated pre-
viously Awang and Wolfe (1969) have found that the selectivity 
of PHT in brominations follows the trend - ketone )) alkene)) 
enol acetate. This would substantia"t~ the view of Arakawa 
(1957c) that bromination of enol acetate yielded the 6-bromo 




Attempts to prepare 5,5-dimE~thyl-4---dimethylamlno-1,3-
cyclohexanedione by reacting 1"'~ bromodimedone with dimethy-
lamine were unsuccessful. 4-Bromo-1 ,J-cyclohexa.nedione exists 
in the keto-enol form, of which there are ·two possible enol 
tautome:r.s, VIa and VIc. 
VIa VIb VIc 
Tautornt~r. Vlb i.s not expected to be the reactive species 
·------------------- -------------
in the reaction between the halide arid.--dTmeJcfiyE:in1ine-:-~T mono-· 
molecular nucleophilic stibs~titution {Snl) reaction· would not 
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be favored since the reactivity of ex -halo;...aldehydes, 
ketones, and acids is rather low in such reactions. A car-
bonium ion at the r:x -carbon will be 'formed very slowly 
because of the positive nature of the carbonyl carbon. 
Very little, if any, stabilization of the carbonium ion is 
to be expected from charge delocalization because the 
resonance structure represented by B has a positive, singly 
bonded oxygen. 
A B 
However, the halogen of an Cf.. ·-haloketone is normally 
readily replaced by a nucleophilic reagent such as HNf~1e 2 in 
a bimolecular nucleophilic substitution (Sn2) reaction. As 
mentioned above, the e:lectron-withdrawing tendency of the 
carbonyl group makes the ()[ .. -carbon f3omewhat positive and, 
therefore, increases its susceptibility to nucleophilic 
·attack. 
_, _ _ 
- - ---- -- ----
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However, the formation of Sn2 transition state intermediate 
resulting from the backside attack of the incoming nucleophile 
is hindered because of steric inhibition in form VIb of 4-
bromodimedone. Examination of Courtauld molecular models 
indicates that the central carbon involved could achieve the 
required degree of coplanarity, but the gem-dimethyl groups 
on the vicinal carbon block the backside attack~ 
The the sarrie token, tautomeric :form VIa should not 
be the most reactive species in ·either an Sn1 or Sn2 reaction. 
Similarly, tautomeric form VIc is not·expeoted to react 
according to an Sn2 mechanism, but it would appear that the 
amination reaction might proceed via an Snl mechanism. 
Dimedone is a monobasic acid with a pKa = 5.15 in 
water. The p~esence of a bromine substituent in the 4-position 
would tend to increase the acidity of tautomeric form VIc so 
that its acidity should be greater ·than that of d:tmedone. 
Therefore, under the reaction conditions in which 
liquid dimethylamine was the soJ.vent. in the aminatio:n, 
tautomeric form VIc will exist predominantly in the corres-
ponding dimethylammonium salt; it is conceivable that the 
salt form could be the reactive species. 
In aither case, as seen from molecular m6dels, the 
presence of the gem--dimethyl groups would appear to impede 
'the formation of the transition complex in an Sn2 mechanism. 
Prom consideration of the possible resonance hybrids of the 
1.~-bromodimedone VI in an Sn1 roacti.on, it does not appear 
that there would be any appreciable resonance stabilization. 
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The positive inductive effect o:f the gem-dimethyl groups is 
not expected to contribute any significant amount of stabili-
zation of the carbonium ion. 
Since. the leaving group, the bromide ion, and the 
attacking nuc.leophile, dimethylamine, are two constants in 
the amina·tion reaction, the nature of the reaction medium 
becomes a variable. In the case of an Sn2 reaction in which 
none of the reactants possesses an electrical charge, the 
transition state would experience charge separation when 
compared to the ground state of the reactants. 
oe 6Q) 
RBr + HNMe 2 --> Br ---R--- NHMe2 
Therefore, if this reaction could occur by an Sn2 mechanism, 
a more polar solvent would enhance the reactivity. 
The transition state in a Snl reaction undergoes 
charge separation: therefore 9 ·!;he effect of performing the 
amination in a more polar solvent will be to increase the 
reaction rate. .·However, the use of ethanol or liquid dime-
thylamine did not exert a sufficient contribution to the low 
inductive and resonance effects to permit the reaction to 
proceed. 'rhe reaction also failed in sueh solvents such as 
benz.ene and diethyl ether. 
Another point to remember about diraethylamine is 
that in its 1iquid.ft?rm, as it exists under the reaction 
·conditions the molecules of dimethylamine would aggregate 
because o:f hydrogen bonding to form polymers. Therefore, the 
·s likel to be a :form of dimethvl-
.am!.ne rather than its monomeric ~form. Such an attacking group 
would probably be too bulky to pt!!rmi t it to approach the 
~eactive center. 
Since there was no definitive evidence that 5,5-
dimethyl-4-dimethylamino-1,3-cyclohexanedione (VIII) was 
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formed, the reasons cited above may be su:f:ficient to explain 
why none of the required amine was isolated under the conditions 
utilized. 
Another route of synthesis for the preparation of the 
title compound was attempted. 4,4~Dimethyl-2,6-cyclo-
hexanedione carboxamide (X) was prepared according to the 
method of Scarborough ( 1961) • This method of preparing the 
.2-.carboxamido derivative o:f dimedone by fusing dimedone with 
urea yielded at best only 30% of' the theoretical amount. 
Another group has obtained the same product in 63% yield using 
Pb(CN0)2 in reflu:d.ng acrylonitrile (Muxfeldt, Grethe, & 
Rogalski, 1966). As precursor to the title compound the 
bromination of tho above amide was attempted.· 1.'he corres-
ponding enol acetate or enol ether could not be prepared. 
Isolation of the NBS bromination products of 2-carbamoyl-5, 
5-dimethyl-1,)-cyclohexanedione {X) yielded starting material 
and 2-bromodimedone (XVIII) only. When PHT was used as the 
brominating reagent only starting material was obtained, 
As stated in the introduction, the purpose of this 
study was to prepare a model com.:pound of ring A of tetracycline 
'"to determine if. it would undergo a 1\~tannich reaction in which 
a.diptych-boroxazolidine (IX) was the amine moiety. The aim 
could be made to proceed or not~ but rather this research was 
-undertaken to discover if this· reaction would occur under the 
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same IV!annich reaction conditions which lead to the formation 
of a hitherto uncharacterized organoboron complex of tetra-
cycline. This information was required for elucidating the 
nature of the tetracycline complex. 
The Mannich reaction is usua1ly performed in water, 
methanol, ethanol, or acetic acid, and it involves the con-
densation of an ald~hyde (usually formaldehyde) with an 
amine and a compound-containing an active hydrogen. The 
. reaction product-is cal-red----a:-Nlannicnbase (Thomps,~n, 1_9_6_5J 
House,,· 1964cr Hellmann, 1963). 
The usual source of formaldehyde is formalin, a 
20-40% aqueous solution of formaldehyde; trioxymethylene, a 
solid trimer; or polyoxymethylene, often called paraformal-
dehyde, a s<:,lid pnlymer. 
The amine is normally introduced as its hydrochloride, 
and a small a.mount of HC1 is often added to ensure that the 
reaction mixture is slightly acidic. The Mannich reaction can 
also proceed under basic conditions. The following mechan-
isms have been proposed (Cummings & Shelt_on, 1960). 
Base catalysed reactionr 
... H". #) 
~)_i'l H + H,C---0 -----::> ri 2 N C 1-12 0 H 
. R
2
N tHz.O H 1- tH C. .H/ __ , l~2NC H2. C H2. C 'R / · H II 
0 . . 0 
------------- -------- -------------------- -- ------ --- --- -- --------------· 




-H o 2 
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. II 
0 
In both cases the aldehyde is attacked by the amine, 
and not by the active hydrogen compound, as had been previousl:y 
believed. In the acid catalysed reaction it is the free amine·-
not the amine salt .. which initiatef~ the attack on ·the aldehyde 
even though it :l.s in an acidic medium. In a subsequent step 
it is the immonium-carbonium ion which interacts with the enol 
(when the active hydrogen compound cari be converted t.o this 
form) to form the protonated Ma.nnich base •. 
In the case of the acid ca.talysed'N-amidoalkylation 
the reaction probably proceeds by the following mechanisnu 
H c HO 1· f-{1J ~ H2C::: ~H 
/--
•• ~~ ® 
HN R t H2_C=O\-I ~~· R:aNHC H2.0H ~--~ R2_NC H.,~O H 
'" H(t) ~H 0 •• ID (f) 






R'C NH C.H N R 
II' 2 l 
0 
48 
In a condensation of an amine with a carbonyl compound 
(for example, formaldehyde) protonation is one of the initial 
steps. It is reasonable to expect the rate to change with 
the pH. At a given pH, two equilibria are possible, namelys 
<37 <t) 
R2NH + H ~ RtNH 2 
e - . <t> 
H~.C:::O +H ~ H2C.=OH 
The next step . involves an electrophilic attack of the 




If the amine is protonated, it is apparent that it 
can not attack the carbon of the carbonyl, which even in its 
unprotonated form has some positive character. Protonation 
of the carbonyl group will enhance its affinity for nucleo-
philic agents, Therefore, there will be an optimal pH at 
which there exists a sufficient concentration of the conjugate 
acid of the carbonyl. compound while at the same time, there 
is a low enough level of the protonated amine moiety which 
will permit the condensation to occur. 
The amine compound chosen for use in the N-amidoalkyla-
tion was formed by condensing phenyl boronic acid with 
diethanolamine to yield .B -phenyl-1,),6,2-dioxazaboracyclo-
octane (IX) 
~0,-o~ 
H-N: B · 
·\__,o' -
IX a IXb 
This compound was chosen because, compared to other 
boronic esters of ordinary alcohols, it exhibited extra-
. ordinary stability with respect to atmospheric oxidation and 
hydrolytic cleavage, In this eight membered ring compound a· 
transannular interaction between the lone pair of electrons 
of nitrogen and the vaccmt orbital of boron is sterically 
favored~ 
It is chiefly the N-? B dative bond formation which 
contributes to the stability of the diptych-boroxazolidine. 
Inspection of the Courtauld ntolecular models indicates that 
bor·oxazolidine formation may also be favored smnewhat since 
its formation is accompanied by a reduction in the hydrogen-
hydrogen and hydrogen-electron lone pair non-·bonding inter-
actionQ However, t~is is expectid to be a minor contributing 
factor. Since a N -·O>- B dative bond is formed, the nitrogen 
atom acquires a "formal" positive charge and the boron atom, 
e. 
Infrared spectra (Zimmermcum, 1.964) and d:l.pole measure-
ments (Zimmermann~ 196h; ci'. Niedenzu & Dawson, 1965) did not 
-•---
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provide conclusive evidence proving the presence of' the N -4 B 
bond. However, the delayed .base reaction of the boroxazoli-
dines are less stable to hydrolysis augments the claim that 
the condensation product of a boronic acid and diethanolamine 
does contain a N ~ B dative bond. This argument is further 
strengthened by the fact that tris-(ethanolamine-borane) 
borate, B(OCH2CH2NH2 •BH3)3, is unstable to hydrolysis in a 
neutral solution (Kelly & Edwards, 1960). In this case, the 
in boroxazolidines, because the amine moiety is coordinated 
with the borane groups. In addition, 2- ( 1-t. •-bromopheny 1)-6-
methyl-1,),6,2-dioxazaboracyclooctane (XVIIIa) or B -(4'-bro-
mophenyl)-N-methyl-diptych-boroxazolidine (XVIIIb) does not 
react readily with Grignard reagents, whereas normal alko.xy .. 
XVIIIa XVIIIb 
boranes do undergo facil<:1 B-C bond· formation under these . 
conditions (Bean & Johnson, 1932; Hoffmann & 'rhomas, 1959). 
11herefore, it is quite well established that the 
N---) B dative bond exists in the boronate esters of diethanol-
amine. I"or that reason, the boroxazolidine (IXb) structure 
rather than that of the dioxazoboracyclooctane (IXa) is used 
in representing the structure of these boronate esters. 
Cleavage of the N -·-> B bond resulting i:n. the formation 
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of the corresponding eight membered monocyclic ring compound 
is presumably the rate determining step in the hydrolysis 
reaction. The overall reaction follows first order kinetics, 
and the rate is dependent upon the boroxazolidine concentration, 
IXb IX a 
not the concentration of the acid or base present (Zimmer-
man, 1964). 
The presence of a N--~ B dative bond attributes a 
positive charge to the nitrogen atom; therefore, it can not 
attack the protonated formaldehyde. 'rhe eight-membered ring 
compound must initiate the attack and, as in hydrolysis, the 
rate determining step will be cleavage of the N ~ B bond. 
'rhis reaction will have to compete with hydrolysis, 
which is likely to predominate, because of the stability of 
the hydrolytic products unless, of coursej hydrolysis ·occurs 




Under slightly stronger acidic conditions, an alte1~ate 
t-------_ __,T._._he_.r_e_s_ul±ant_Etc¥1aminome~hy-l-Ga-!'-bGn-iurn=-immo.n-ium-ion-----
could then attack the nitrogen atom of the boronate.ester in 
its dioxazaboracyclooctane form.. 'l1he stronger acid conditions 
required for this mechanism increases the probability that 
· hydrolysis will occur. 
It was rfJalized . that the boronate ester of diethano-
lamine exists predominantly in the boroxazolidine form, but 
it war-1 hoped that the reaction cond:t tions would effect 
sufficient N---> B cleavage to allow the Mannich reaction to 
proceed and that this would be favored over hydrc.dys·is. 
A !'.'lannich reaction involving boroxazolidine {IX), 
formaldehydE), and l} ,4-dirnethyl-2, 6.-eyclohexanedione carboxa-
mide(X) was unsuccessful. Boroxazolidine (IXb) was recovered 
in 80%-90% yield. None of the desired Mannich base was 
isolated, and there was no evidence to suggest that J.t was 
formed. In order to s imu.late the interaction which may have 
tal< en place between the d irncthylamino group and its enollc 
hydroxyl group in the title compound, an equivalent amount 
----of'-ij-rif.Ybhy~J:am:tne--was---added--to--:the re-act toh mixture • - Jtgain the 
Ma.nnich reaction apparently did not proceed since only start-
ing materials were recovered •. 
53 
Therefore, it' would appear that the boroxazolidine 
(IXb) is much more stable than.its corresponding dioxazobora-
cyclooctane (IXa) under the reaction conditions utilized in 
the attempted Mannich reaction involving 4,4-dimethyl-2,6-
cyclohexanedione carboxamide (X). There was no indication 
that any other reaction had occurred. 
If this information applies to tetracyclin~, it would 
suggest that the Mannich reaction using a boroxazolidine· as 
fore the nature of the reaction between tetracycline and 
boroxa·zolidine still remains to be clarified. 
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